Prognostic factors in soft-tissue sarcomas: what have we learnt?

References

• Abernethy J. Surgical aberrations. Journal of Surgical Aberrations2, 17–30 (1817).
   Google Scholar
• Skubitz KM, D’Adamo DR. Sarcoma. Mayo Clin. Proc.82(11), 1409–1432 (2007).
   PubMed Web of Science ®Google Scholar
• Gross S. Sarcoma of the long bones: based on a study of one hundred and sixty five cases. Am J. Med. Sci.155, 17–57 (1879).
   Google Scholar
• Lieberman Z, Ackerman L. Principles in management of soft tissue sarcomas: a clinical and pathologic review of one hundred cases. Surgery35(Suppl. 3), 350–365 (1954).
   PubMedGoogle Scholar
• Enneking W, Spanier S, Malawer M. The effect of the anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh. Cancer47, 1005–1022 (1981).
   PubMed Web of Science ®Google Scholar
• Strander H, Turesson I, Cavallin-Stahl E. A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol.42(5–6), 516–531 (2003).
   PubMed Web of Science ®Google Scholar
• Hui A, Ngan S, Wong K, Powell G, Choong P. Preoperative radiotherapy for soft tissue sarcoma: the Peter MacCallum Cancer Centre experience. Eur. J. Surg. Oncol.32, 1159–1164 (2006).
   PubMedGoogle Scholar
• Choong PF, Petersen IA, Nascimento AG, Sim FH. Is radiotherapy important for low-grade soft tissue sarcoma of the extremity? Clin. Orthop. Relat. Res.387, 191–199 (2001).
   Google Scholar
• Delaney T, Yang J, Glatstein E. Adjuvant therapy for adult patients with soft tissue sarcomas. Oncology5, 105–118 (1991).
   PubMedGoogle Scholar
• Coindre JM, Terrier P, Bui NB et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J. Clin. Oncol.14(3), 869–877 (1996).
   PubMed Web of Science ®Google Scholar
• Bauer HC, Trovik CS, Alvegard TA et al. Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop. Scand.72(2), 150–159 (2001).
   PubMed Web of Science ®Google Scholar
• Nijhuis PH, Schaapveld M, Otter R, Molenaar WM, van der Graaf WT, Hoekstra HJ. Epidemiological aspects of soft tissue sarcomas (STS) – consequences for the design of clinical STS trials. Eur. J. Cancer35(12), 1705–1710 (1999).
   PubMed Web of Science ®Google Scholar
• Stojadinovic A, Leung DH, Hoos A, Jaques DP, Lewis JJ, Brennan MF. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann. Surg.235(3), 424–434 (2002).
   PubMed Web of Science ®Google Scholar
• Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J. Clin. Oncol.14(5), 1679–1689 (1996).
   PubMed Web of Science ®Google Scholar
• Benjamin RS, Wiernik PH, Bachur NR. Adriamycin: a new effective agent in the therapy of disseminated sarcomas. Med. Pediatr. Oncol.1(1), 63–76 (1975).
   PubMedGoogle Scholar
• Blum RH, Carter SK. Adriamycin. A new anticancer drug with significant clinical activity. Ann. Intern. Med.80(2), 249–259 (1974).
   PubMed Web of Science ®Google Scholar
• Tierney JF, Mosseri V, Stewart LA, Souhami RL, Parmar MK. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br. J. Cancer72(2), 469–475 (1995).
   PubMed Web of Science ®Google Scholar
• Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet350(9092) 1647–1654 (1997).
   PubMedGoogle Scholar
• Lewis JJ, Leung D, Casper ES, Woodruff J, Hajdu SI, Brennan MF. Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma. Arch. Surg.134(2), 190–194 (1999).
   PubMedGoogle Scholar
• Fleming JB, Berman RS, Cheng SC et al. Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J. Clin. Oncol.17(9), 2772–2780 (1999).
   PubMed Web of Science ®Google Scholar
• Rydholm A, Gustafson P. Should tumor depth be included in prognostication of soft tissue sarcoma? BMC Cancer3, 17 (2003).
   PubMed Web of Science ®Google Scholar
• Ferrario T, Karakousis CP. Retroperitoneal sarcomas: grade and survival. Arch. Surg.138(3), 248–251 (2003).
   PubMedGoogle Scholar
• Stojadinovic A, Yeh A, Brennan MF. Completely resected recurrent soft tissue sarcoma: primary anatomic site governs outcomes. J. Am. Coll. Surg.194(4), 436–447 (2002).
   PubMedGoogle Scholar
• Engellau J, Bendahl PO, Persson A et al. Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays. Hum. Pathol.36(9), 994–1002 (2005).
   PubMed Web of Science ®Google Scholar
• Evans HL. Atypical lipomatous tumor, its variants, and its combined forms: a study of 61 cases, with a minimum follow-up of 10 years. Am. J. Surg. Pathol.31(1), 1–14 (2007).
   PubMed Web of Science ®Google Scholar
• ten Heuvel SE, Hoekstra HJ, van Ginkel RJ, Bastiaannet E, Suurmeijer AJ. Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up. Ann. Surg. Oncol.14(1), 222–229 (2007).
   PubMedGoogle Scholar
• Fiore M, Grosso F, Lo Vullo S et al. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution. Cancer109(12), 2522–2531 (2007).
   PubMed Web of Science ®Google Scholar
• Gutierrez JC, Perez EA, Franceschi D, Moffat FL Jr, Livingstone AS, Koniaris LG. Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. J. Surg. Res.141(1), 105–114 (2007).
   PubMed Web of Science ®Google Scholar
• Criscione VD, Weinstock MA. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J. Am. Acad. Dermatol.56(6), 968–973 (2007).
   PubMed Web of Science ®Google Scholar
• Popov P, Bohling T, Asko-Seljavaara S, Tukiainen E. Microscopic margins and results of surgery for dermatofibrosarcoma protuberans. Plast. Reconstr. Surg.119(6), 1779–1784 (2007).
   PubMed Web of Science ®Google Scholar
• Blazer DG III, Sabel MS, Sondak VK. Is there a role for sentinel lymph node biopsy in the management of sarcoma? Surg. Oncol.12(3), 201–206 (2003).
   PubMedGoogle Scholar
• Behranwala KA, A’Hern R, Omar AM, Thomas JM. Prognosis of lymph node metastasis in soft tissue sarcoma. Ann. Surg. Oncol.11(7), 714–719 (2004).
   PubMed Web of Science ®Google Scholar
• Kayton ML, Meyers P, Wexler LH, Gerald WL, LaQuaglia MP. Clinical presentation, treatment, and outcome of alveolar soft part sarcoma in children, adolescents, and young adults. J. Pediatr. Surg.41(1), 187–193 (2006).
   PubMed Web of Science ®Google Scholar
• Kebudi R, Ayan I, Gorgun O, Agaoglu FY, Vural S, Darendeliler E. Brain metastasis in pediatric extracranial solid tumors: survey and literature review. J. Neurooncol71(1), 43–48 (2005).
   PubMed Web of Science ®Google Scholar
• Paulino AC, Nguyen TX, Barker JL Jr. Brain metastasis in children with sarcoma, neuroblastoma, and Wilms’ tumor. Int. J. Radiat. Oncol. Biol. Phys.57(1), 177–183 (2003).
   PubMed Web of Science ®Google Scholar
• Nowain A, Bhakta H, Pais S, Kanel G, Verma S. Gastrointestinal stromal tumors: clinical profile, pathogenesis, treatment strategies and prognosis. J. Gastroenterol. Hepatol.20(6), 818–824 (2005).
   PubMedGoogle Scholar
• Clary BM, DeMatteo RP, Lewis JJ, Leung D, Brennan MF. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. Ann. Surg. Oncol.8(4), 290–299 (2001).
   PubMed Web of Science ®Google Scholar
• Liebl LS, Elson F, Quaas A, Gawad KA, Izbicki JR. Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma. Anticancer Res.27(4C), 2897–902 (2007).
   PubMedGoogle Scholar
• Temple LK, Brennan MF. The role of pulmonary metastasectomy in soft tissue sarcoma. Semin. Thorac. Cardiovasc. Surg.14(1), 35–44 (2002).
   PubMedGoogle Scholar
• Van Glabbeke M, van Oosterom AT, Oosterhuis JW et al. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens – a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J. Clin. Oncol.17(1), 150–157 (1999).
   PubMed Web of Science ®Google Scholar
• Hosoi H, Teramukai S, Matsumoto Y et al. A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan. Int. J. Clin. Oncol.12(2), 137–45 (2007).
   PubMedGoogle Scholar
• Walterhouse D, Watson A. Optimal management strategies for Rhabdomyosarcoma in children. Paediatr. Drugs9(6), 391–400 (2007).
   PubMedGoogle Scholar
• Joensuu H, Roberts PJ, Sarlomo-Rikala M et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N. Engl. J. Med.344(14), 1052–1056 (2001).
   PubMed Web of Science ®Google Scholar
• Eilber FC, Brennan MF, Eilber FR et al. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann. Surg.246(1), 105–113 (2007).
   PubMed Web of Science ®Google Scholar
• Coindre JM. Grading of soft tissue sarcomas: review and update. Arch. Pathol. Lab. Med.130(10), 1448–1453 (2006).
   PubMed Web of Science ®Google Scholar
• Broders A. Squamous cell epithelioma of the lip: a study of 537 cases. JAMA74, 656–664 (1920).
   Google Scholar
• Broders A, Hargrave R, Meyerding H. Pathological features of soft tissue fibrosarcoma with special reference to the grading of its malignancy. Surg. Gynaecol. Obstet.69, 267–280 (1939).
   Google Scholar
• Pritchard DJ, Soule EH, Taylor WF, Ivins JC. Fibrosarcoma – a clinicopathologic and statistical study of 199 tumors of the soft tissues of the extremities and trunk. Cancer33(3), 888–897 (1974).
   PubMed Web of Science ®Google Scholar
• Suit HD, Russell WO, Martin RG. Sarcoma of soft tissue: clinical and histopathologic parameters and response to treatment. Cancer35(5), 1478–1483 (1975).
   PubMed Web of Science ®Google Scholar
• Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcomas. Results of a clinicohisto-pathologic correlation in a series of 163 cases. Cancer53(3), 530–541 (1984).
   PubMed Web of Science ®Google Scholar
• Gustafson P. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop. Scand.259(Suppl.) 1–31 (1994).
   Google Scholar
• Hashimoto H, Daimaru Y, Takeshita S, Tsuneyoshi M, Enjoji M. Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer70(12), 2816–2822 (1992).
   PubMed Web of Science ®Google Scholar
• Myhre-Jensen O, Kaae S, Madsen EH, Sneppen O. Histopathological grading in soft-tissue tumors. Relation to survival in 261 surgically treated patients. Acta Pathol. Microbiol. Immunol. Scand. [A]91(2), 145–150 (1983).
   PubMedGoogle Scholar
• van Unnik JA, Coindre JM, Contesso C et al. Grading of soft tissue sarcomas: experience of the EORTC Soft Tissue and Bone Sarcoma Group. Eur. J. Cancer29A(15), 2089–2093 (1993).
   PubMed Web of Science ®Google Scholar
• Trojani M, Contesso G, Coindre JM et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int. J. Cancer33(1), 37–42 (1984).
   PubMed Web of Science ®Google Scholar
• Bergh P, Meis-Kindblom JM, Gherlinzoni F et al. Synovial sarcoma: identification of low and high risk groups. Cancer85(12), 2596–2607 (1999).
   PubMed Web of Science ®Google Scholar
• Evans HL. Classification and grading of soft-tissue sarcomas. A comment. Hematol. Oncol. Clin. North Am.9(3), 653–656 (1995).
   PubMedGoogle Scholar
• Milross CG, Tucker SL, Mason KA, Hunter NR, Peters LJ, Milas L. The effect of tumor size on necrosis and polarographically measured pO2. Acta Oncol.36(2), 183–189 (1997).
   PubMed Web of Science ®Google Scholar
• Spratt JS, Meyer JS, Spratt JA. Rates of growth of human solid neoplasms: Part I. J. Surg. Oncol.60(2), 137–146 (1995).
   PubMed Web of Science ®Google Scholar
• Risau W. Mechanisms of angiogenesis. Nature386(6626), 671–674 (1997).
   PubMed Web of Science ®Google Scholar
• Kerbel RS. Significance of tumor–host interactions in cancer growth and metastases. Cancer Metastasis Rev.14(4), 259–262 (1995).
   PubMed Web of Science ®Google Scholar
• Domanski HA. Fine-needle aspiration cytology of soft tissue lesions: diagnostic challenges. Diagn. Cytopathol.35(12), 768–773 (2007).
   PubMed Web of Science ®Google Scholar
• Domanski HA, Akerman M, Carlen B et al. Core-needle biopsy performed by the cytopathologist: a technique to complement fine-needle aspiration of soft tissue and bone lesions. Cancer105(4), 229–239 (2005).
   PubMed Web of Science ®Google Scholar
• Mitsuyoshi G, Naito N, Kawai A et al. Accurate diagnosis of musculoskeletal lesions by core needle biopsy. J. Surg. Oncol.94(1), 21–27 (2006).
   PubMedGoogle Scholar
• Heslin MJ, Lewis JJ, Woodruff JM, Brennan MF. Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann. Surg. Oncol.4(5), 425–431 (1997).
   PubMed Web of Science ®Google Scholar
• Hoeber I, Spillane AJ, Fisher C, Thomas JM. Accuracy of biopsy techniques for limb and limb girdle soft tissue tumors. Ann. Surg. Oncol.8(1), 80–87 (2001).
   PubMed Web of Science ®Google Scholar
• Cancer AJCO. AJCC Cancer Staging Manual. In: AJCC Cancer Staging Manual. Lippincott-Raven, PA, USA (1997).
   Google Scholar
• Wunder JS, Healey JH, Davis AM, Brennan MF. A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer88(12), 2721–2730 (2000).
   PubMed Web of Science ®Google Scholar
• Choong PF, Gustafson P, Willen H et al. Prognosis following locally recurrent soft-tissue sarcoma. A staging system based on primary and recurrent tumor characteristics. Int. J. Cancer60(1), 33–37 (1995).
   PubMed Web of Science ®Google Scholar
• Mankin HJ, Fondren G, Hornicek FJ, Gebhardt MC, Rosenberg AE. The use of flow cytometry in assessing malignancy in bone and soft tissue tumors. Clin. Orthop. Relat. Res.397, 95–105 (2002).
   Google Scholar
• Ettinger SN, Scase TJ, Oberthaler KT et al. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996–2002). J. Am. Vet. Med. Assoc.228(7), 1053–1062 (2006).
   PubMedGoogle Scholar
• Hasegawa T. Histological grading and MIB-1 labeling index of soft-tissue sarcomas. Pathol. Int.57(3), 121–125 (2007).
   PubMed Web of Science ®Google Scholar
• Fernebro J, Engellau J, Persson A, Rydholm A, Nilbert M. Standardizing evaluation of sarcoma proliferation – higher Ki-67 expression in the tumor periphery than the center. APMIS115(6), 707–712 (2007).
   PubMedGoogle Scholar
• Choong PF, Akerman M, Willen H et al. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific? APMIS103(11), 797–805 (1995).
   PubMedGoogle Scholar
• Sabah M, Cummins R, Leader M, Kay E. Immunoreactivity of p53, Mdm2, p21(WAF1/CIP1) Bcl-2, and Bax in soft tissue sarcomas: correlation with histologic grade. Appl. Immunohistochem. Mol. Morphol.15(1), 64–69 (2007).
   PubMedGoogle Scholar
• Ottaiano A, De Chiara A, Fazioli F et al. Biological prognostic factors in adult soft tissue sarcomas. Anticancer Res.25(6C), 4519–26 (2005).
   PubMedGoogle Scholar
• Bartel F, Schulz J, Bohnke A et al. Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis. Int. J. Cancer117(3), 469–475 (2005).
   PubMedGoogle Scholar
• Oda Y, Yamamoto H, Takahira T et al. Frequent alteration of p16INK4a/p14ARF and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14ARF expression both correlate with poor prognosis. J. Pathol.207(4), 410–421 (2005).
   PubMed Web of Science ®Google Scholar
• Riggi N, Cironi L, Suva ML, Stamenkovic I. Sarcomas: genetics, signalling, and cellular origins. Part 1: the fellowship of TET. J. Pathol.213(1), 4–20 (2007).
   PubMed Web of Science ®Google Scholar
• Ladanyi M, Antonescu CR, Leung DH et al. Impact of SYT–SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res.62(1), 135–140 (2002).
   PubMed Web of Science ®Google Scholar
• Panagopoulos I, Mertens F, Isaksson M et al. Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer31(4), 362–372 (2001).
   PubMed Web of Science ®Google Scholar
• Amary MF, Berisha F, Bernardi Fdel C et al. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma. Mod. Pathol.20(4), 482–496 (2007).
   PubMedGoogle Scholar
• Nielsen T. Microarray analysis of sarcomas. Adv. Anat. Pathol.13(4), 166–173 (2006).
   PubMedGoogle Scholar
• Schena M, Shalon D, Davis R, Brown P. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science270(5235), 467–470 (1995).
   PubMed Web of Science ®Google Scholar
• Tschoep K, Kohlmann A, Schlemmer M, Haferlach T, Issels RD. Gene expression profiling in sarcomas. Crit. Rev. Oncol. Hematol.63(2), 111–124 (2007).
   PubMed Web of Science ®Google Scholar
• Francis P, Namlos HM, Muller C et al. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential. BMC Genomics8, 73 (2007).
   PubMed Web of Science ®Google Scholar
• Lee YF, John M, Falconer A et al. A gene expression signature associated with metastatic outcome in human leiomyosarcomas. Cancer Res.64(20), 7201–7204 (2004).
   PubMed Web of Science ®Google Scholar
• Fernebro J, Francis P, Eden P et al. Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma. Int. J. Cancer118(5), 1165–1172 (2006).
   PubMed Web of Science ®Google Scholar
• Kasper B, Gil T, D’Hondt V, Gebhart M, Awada A. Novel treatment strategies for soft tissue sarcoma. Crit. Rev. Oncol. Hematol.62(1), 9–15 (2007).
   PubMedGoogle Scholar
• Borst P, Evers R, Kool M, Wijnholds J. A family of drug trasnporters: the multidrug resistance-associated proteins. J. Natl Cancer Inst.92, 1295–1302 (2000).
   PubMed Web of Science ®Google Scholar
• Nagata S. Apoptosis by death factor. Cell88, 355–365 (1997).
   PubMed Web of Science ®Google Scholar
• Johntone R, Ruefli A, Tainton KM, Smyth M. A role for P-glycoprotein in regulating cell death. Leuk. Lymphoma38, 1–11 (2000).
   PubMedGoogle Scholar
• Torihashi S, Horisawa M, Watanabe Y. c-Kit immunoreactive interstitial cells in the human gastrointestinal tract. J. Auton. Nerv. Syst.75, 38–50 (1999).
   PubMedGoogle Scholar
• Plaat B, Hollema H, Molenaar WM et al. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J. Clin. Oncol.18, 3211–3220 (2000).
   PubMed Web of Science ®Google Scholar
• Maki RG. Recent advances in therapy for gastrointestinal stromal tumors. Curr. Oncol. Rep.9(3), 165–169 (2007).
   PubMedGoogle Scholar
• McArthur GA. Molecular targeting of dermatofibrosarcoma protuberans: a new approach to a surgical disease. J. Natl Compr. Canc. Netw.5(5), 557–562 (2007).
   PubMedGoogle Scholar